Healthconn Corp

HEALTHCONN CORP. has a debt-to-equity ratio of 0.3, indicating a relatively conservative capital structure. However, the company's cash and equivalents of TWD 11,886,000 are significantly lower than its long-term debt of TWD 276,305,000, resulting in a negative net cash position. The current ratio of 1.78 suggests the company has sufficient short-term assets to cover its liabilities, but liquidity remains a concern given the negative net cash. Profitability metrics show a return on equity (ROE) of 0.91% and a return on assets (ROA) of 0.56%, both below the typical thresholds for high-performing healthcare firms. The operating margin is 2.93% (TWD 3,318,000 operating income / TWD 113,099,500 revenue), and the net margin is 0.74% (TWD 8,394,000 net income / TWD 113,099,500 revenue), indicating limited profitability relative to revenue. These figures are below the median for the Advanced Medical Equipment & Technology industry. The company's revenue is concentrated in two geographic markets: Taiwan and mainland China. No further breakdown of segment performance is available in the input data, but the geographic concentration introduces exposure to regional regulatory and economic shifts. The company's operations are not diversified across multiple product lines or geographic regions. HEALTHCONN CORP. reported revenue of TWD 113,099,500 in the latest period, with no forward-looking revenue guidance provided. The capital expenditure of TWD -23,671,000 suggests a reduction in investment in physical assets, which may reflect a strategic shift or financial constraints. The company's free cash flow of TWD 1,821,000 is minimal, limiting its ability to reinvest in growth or return capital to shareholders. The risk assessment highlights medium liquidity risk and low dilution risk. The negative net cash position is a key flag, as the company's cash reserves are insufficient to cover its long-term debt. No dilution risk is currently present, as shares outstanding remain unchanged between basic and diluted measures. However, the company may face pressure to raise capital in the future, which could lead to equity dilution. No recent filings or transcripts are provided in the input data to inform recent events or strategic developments. The absence of forward-looking statements or guidance limits the ability to assess the company's near-term direction.